William W. Busse

Mar 21, 2023 | thelancet.com | William W. Busse |Stanley J. Szefler

We live and benefit from life in a digital world.

Feb 3, 2023 | jacionline.org | Alberto Papi |Mario Castro |Kansas City |William W. Busse

Prior asthma exacerbations have been associated with lung function decline and increased risk of future exacerbations. Dupilumab, a human monoclonal antibody, blocks IL-4/IL-13, key central drivers of type 2 inflammation. We investigated the relationship between prior exacerbations and lung function in patients with moderate-to-severe type 2 asthma (blood eosinophils ≥150cells/μL or FeNO ≥25ppb at parent study baseline [PSBL]) from QUEST (NCT02414854) who enrolled in TRAVERSE (NCT02134028).